LALama A. Aldammas

Lama A. Aldammas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lama A. Aldammas has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • Abdullah M. Alrajhi

    Department of Pharmacy, OncoClinc, Riyadh, Saudi Arabia; Department of Pharmacy Practice, College of Pharmacy, Alfaisal University, Riyadh, Saudi Arabia; Clinical Pharmacy Department, King Fahd Medical City, Riyadh, Saudi Arabia, Saudi Arabia

    1 shared publication
  • Nora Alkhudair

    Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia

    1 shared publication
  • Rawan F. Alzaidi

    Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia; Department of Pharmacy Services, King Saud University Medical City, Riyadh, Saudi Arabia, Saudi Arabia

    1 shared publication
  • Yahya M. K. Tawfik

    Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia

    1 shared publication

Latest Publications

  • Open Access

    Medication Adherence and Quality of Life Among Patients with Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors in Saudi Arabia: A Cross-Sectional Study

    by Rawan. F Alzaidi, Yahya M. K. Tawfik, Abdullah Alrajhi, Lama A. Aldammas, Nora A. Alkhudair

    Tyrosine kinase inhibitors (TKIs) have transformed the treatment of chronic myeloid leukemia (CML) patients, enabling long-term disease control while highlighting quality of life (QoL) and medication adherence. In Saudi Arabia, data on the relationship of TKI adherence and QoL remains limited. This study evaluated QoL, medication adherence, and their associated factors. A cross-sectional study of adult CML patients on TKI therapy at two Saudi tertiary centers assessed QoL using the EORTC QLQ-CML24 and QLQ-C30, and adherence using the MARS-5. Linear regression analyzed factors associated with global health status, while logistic regression examined factors associated with adherence. Among 100 patients (mean age 46.99 ± 14.26 years) 48% were female and 61% were adherent. Adherent patients had better emotional functioning, with significant lower fatigue, nausea and vomiting, pain, dyspnea, insomnia, and financial difficulties (all p < 0.05). Female sex was independently associated with higher odds of adherence (aOR 3.15, 95% CI 1.05–9.45, p = 0.041). Adherence was associated with a higher global health status score, but not significantly (adjusted β = 4.40, 95% CI -3.81–12.61, p = 0.289). These findings support integrating adherence assessment with patient-reported outcomes and warrant prospective studies to establish this relationship.